• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

HeartMate II 左心室辅助装置的早期泵功率升高并不预测晚期不良事件。

Early elevations in pump power with the HeartMate II left ventricular assist device do not predict late adverse events.

机构信息

Department of Cardiothoracic Surgery, St. Vincent Heart Center of Indiana, Indianapolis, Indiana.

Research and Scientific Affairs, Thoratec Corporation, Pleasanton, California.

出版信息

J Heart Lung Transplant. 2014 Aug;33(8):809-15. doi: 10.1016/j.healun.2014.02.024. Epub 2014 Feb 26.

DOI:10.1016/j.healun.2014.02.024
PMID:24735680
Abstract

BACKGROUND

The aim of this study was to evaluate the prevalence of early pump power elevation events in patients with the HeartMate II (HMII) and its impact on subsequent development of stroke and pump thrombosis.

METHODS

We analyzed >45,000 measurements of pump power and pump speed measured during the initial hospitalization period and >12,000 follow-up measurements obtained from 138 consecutive patients implanted with a HMII between January 2009 and December 2012. An early power elevation (PEL) event was defined as power ≥10 W within the first 14 post-operative days. Patients were divided into two groups: those with an early PEL event and those without (NP).

RESULTS

Median follow-up duration was 316 (range 2 to 1,264) days. Twenty-seven (20%) patients had early PEL events that lasted for a total duration of 4 (range 1 to 77) hours per patient. Pump speed averaged 9,400 rpm in both groups. Although patients in the PEL group had higher median power (7.1 [6.0 to 9.9] W vs 6.7 [5.7 to 7.8] W, p < 0.001) in the immediate post-operative period, there was no difference between the two groups noted at first follow-up (6.6 [5.9 to 8.7] W vs 6.7 [5.5 to 7.7] W, p = 0.940). No differences in the prevalence of hemorrhagic stroke (4% vs 3%, p = 0.56), ischemic stroke (0% vs 4%, p = 0.41), hemolysis (7% vs 5%, p = 0.32), pump thrombosis (7% vs 4%, p = 0.21) or survival (76% at 1 year in both groups) were found between the two groups.

CONCLUSIONS

In this single-center experience, PEL events that occurred early all resolved by discharge. No relationship was found between early PEL events and subsequent development of pump thrombosis, hemorrhagic stroke or ischemic stroke.

摘要

背景

本研究旨在评估 HeartMate II(HMII)患者早期泵功率升高事件的发生率及其对随后发生卒中与泵血栓形成的影响。

方法

我们分析了 2009 年 1 月至 2012 年 12 月期间连续 138 例植入 HMII 的患者在住院期间的超过 45000 次泵功率和泵速测量值以及超过 12000 次随访测量值。早期功率升高(PEL)事件定义为术后 14 天内功率≥10W。患者分为两组:早期 PEL 事件组和无早期 PEL 事件组(NP)。

结果

中位随访时间为 316(2-1264)天。27 例(20%)患者发生早期 PEL 事件,每位患者的总持续时间为 4(1-77)小时。两组患者的平均泵速均为 9400rpm。尽管 PEL 组患者在术后即刻的中位功率更高(7.1[6.0-9.9]W 比 6.7[5.7-7.8]W,p<0.001),但在首次随访时两组间无差异(6.6[5.9-8.7]W 比 6.7[5.5-7.7]W,p=0.940)。两组患者的出血性卒中发生率(4%比 3%,p=0.56)、缺血性卒中发生率(0%比 4%,p=0.41)、溶血发生率(7%比 5%,p=0.32)、泵血栓形成发生率(7%比 4%,p=0.21)或生存率(两组患者 1 年时生存率均为 76%)均无差异。

结论

在本单中心经验中,早期发生的 PEL 事件均在出院前得到解决。早期 PEL 事件与随后发生的泵血栓形成、出血性卒中或缺血性卒中之间未发现关联。

相似文献

1
Early elevations in pump power with the HeartMate II left ventricular assist device do not predict late adverse events.HeartMate II 左心室辅助装置的早期泵功率升高并不预测晚期不良事件。
J Heart Lung Transplant. 2014 Aug;33(8):809-15. doi: 10.1016/j.healun.2014.02.024. Epub 2014 Feb 26.
2
Pre-operative risk factors of bleeding and stroke during left ventricular assist device support: an analysis of more than 900 HeartMate II outpatients.左心室辅助装置支持期间出血和中风的术前风险因素:超过 900 例 HeartMate II 门诊患者的分析。
J Am Coll Cardiol. 2014 Mar 11;63(9):880-8. doi: 10.1016/j.jacc.2013.08.1656. Epub 2013 Dec 11.
3
Early power elevations and adverse events with the HeartMate II left ventricular assist device: An unsettled issue.HeartMate II左心室辅助装置的早期功率升高及不良事件:一个尚未解决的问题。
J Heart Lung Transplant. 2014 Nov;33(11):1200-1. doi: 10.1016/j.healun.2014.09.003. Epub 2014 Sep 10.
4
Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS) analysis of pump thrombosis in the HeartMate II left ventricular assist device.INTERMACS(机械辅助循环支持机构注册研究)分析 HeartMate II 左心室辅助装置中的泵血栓形成。
J Heart Lung Transplant. 2014 Jan;33(1):12-22. doi: 10.1016/j.healun.2013.11.001. Epub 2013 Nov 27.
5
Factors Related to Pump Thrombosis With the Heartmate II Left Ventricular Assist Device.与Heartmate II左心室辅助装置相关的泵血栓形成因素。
J Card Surg. 2015 Oct;30(10):775-80. doi: 10.1111/jocs.12607. Epub 2015 Aug 18.
6
Adverse events in contemporary continuous-flow left ventricular assist devices: A multi-institutional comparison shows significant differences.当代连续血流左心室辅助装置中的不良事件:多机构比较显示出显著差异。
J Thorac Cardiovasc Surg. 2016 Jan;151(1):177-89. doi: 10.1016/j.jtcvs.2015.09.100. Epub 2015 Nov 4.
7
Use of left ventricular assist device (HeartMate II): a Singapore experience.左心室辅助装置(HeartMate II)的应用:新加坡的经验
Artif Organs. 2014 Jul;38(7):543-8. doi: 10.1111/aor.12247. Epub 2014 Jan 7.
8
Post-operative heparin may not be required for transitioning patients with a HeartMate II left ventricular assist system to long-term warfarin therapy.对于使用 HeartMate II 左心室辅助系统的患者,术后可能不需要肝素即可过渡到长期华法林治疗。
J Heart Lung Transplant. 2010 Jun;29(6):616-24. doi: 10.1016/j.healun.2010.02.003. Epub 2010 Apr 18.
9
Hemolysis in left ventricular assist device: a retrospective analysis of outcomes.左心室辅助装置中的溶血:结局的回顾性分析。
J Heart Lung Transplant. 2014 Jan;33(1):44-50. doi: 10.1016/j.healun.2013.08.019. Epub 2013 Nov 14.
10
The spectrum of complications following left ventricular assist device placement.左心室辅助装置植入术后的并发症谱。
J Card Surg. 2012 Sep;27(5):630-8. doi: 10.1111/j.1540-8191.2012.01504.x.

引用本文的文献

1
Totally percutaneous endovascular repair of HeartMate 3 ventricular assistive device outflow graft pseudoaneurysm.HeartMate 3心室辅助装置流出道移植物假性动脉瘤的完全经皮血管腔内修复术。
J Vasc Surg Cases Innov Tech. 2020 Sep 12;6(4):505-508. doi: 10.1016/j.jvscit.2020.09.001. eCollection 2020 Dec.
2
Reviewing the clinical utility of ventricular assist device log files.评估心室辅助装置日志文件的临床效用。
Indian J Thorac Cardiovasc Surg. 2020 Aug;36(Suppl 2):247-255. doi: 10.1007/s12055-019-00891-2. Epub 2020 Feb 27.
3
Right Heart Catheterization-Background, Physiological Basics, and Clinical Implications.
右心导管检查——背景、生理基础及临床意义
J Clin Med. 2019 Aug 28;8(9):1331. doi: 10.3390/jcm8091331.
4
Stroke and Intracranial Hemorrhage in HeartMate II and HeartWare Left Ventricular Assist Devices: A Systematic Review.HeartMate II和HeartWare左心室辅助装置相关的中风和颅内出血:一项系统评价
Neurocrit Care. 2017 Aug;27(1):17-25. doi: 10.1007/s12028-017-0386-7.
5
Simultaneous ramp right heart catheterization and echocardiography in a ReliantHeart left ventricular assist device.在使用ReliantHeart左心室辅助装置时同步进行右心导管检查和超声心动图检查。
World J Cardiol. 2017 Jan 26;9(1):55-59. doi: 10.4330/wjc.v9.i1.55.